Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • DE • USD
Biofrontera AG (BFAGY) and trades at $2.48.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.2, Earnings Per Share (EPS) of $-0.77, annual revenue of $25.74M.
The stock has a beta of 0.00, operates in the Healthcare sector.
Be the first to know when stocks drop below their intrinsic value.
